QuantuMDx is dedicated to making transformative, quality diagnostic technologies accessible to everyone, so that diseases can be detected and treated earlier, and transmission eradicated.
We’re on the precipice of achieving truly monumental strides for gender equality. Progress has been made in recent years to achieve gender equality for women globally; in 46 countries women
2 February 2017, Newcastle upon Tyne, UK QuantuMDx Group announce an assay co-development and commercialisation agreement with The Global Good Fund, managed by Intellectual Ventures, to develop a rapid, low-cost
15 December 2016, Newcastle upon Tyne QuantuMDx today announced the appointment of CEO Elaine Warburton OBE to the Precision Medicine Catapult Board of Directors as Non Executive Director. Recognised with
28th November 2016, Newcastle upon Tyne, UK QuantuMDx announced today that it received funding from the Bill & Melinda Gates Foundation to further develop and test its CAPTURE-XT™ pathogen concentration
07 November 2016, Newcastle upon Tyne QuantuMDx CEO Elaine Warburton OBE has been invited by Prime Minister Theresa May to join a small group of delegates representing the best of
Ada Lovelace Day is an international day in celebration of the achievements of women in Science, Technology, Engineering, and Maths (STEM). The day aims to increase the profile of women
Lugano, Switzerland, October 10, 2016. Helsinn Investment Fund S.A., a fund focused on early-stage investments in areas of high unmet patient need, today it has been announced that Helsinn Investment
Superbugs – infections that have developed resistance to some, or all antibiotics – could kill 10 million people a year by 2050, Lord Jim O’Neill has warned in his final
Building on the achievements of the Millennium Development Goals, World Malaria Day this year is exploring ways to ‘End Malaria for Good’. The theme is focusing on the recently launched
